Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

bedaquiline

- PMLiVE

Janssen unveils €30,000 prize fund for health tech innovation

Will look for 'transformational ideas' in homecare, adherence and personal health management

Janssen adds Astellas JAK inhibitor to its immunology portfolio

Licenses oral rheumatoid arthritis and psoriasis candidate ASP015K

European approvals for J&J cancer treatments

EC passes new Dacogen indications and backs subcutaneous Velcade

- PMLiVE

Janssen and Merck & Co share UK Prix Galien for hepatitis C drugs

Incivo and Victrelis joint winners of Innovative Product Award

- PMLiVE

Janssen and Merck & Co share UK Prix Galien for hepatitis C drugs

Incivo and Victrelis joint winners of Innovative Product Award

- PMLiVE

Smokefree brief for Two Birds One Stone

NHS Wakefield appoints youth PR agency to handle Smokefree Wakefield campaign

European Commission launches iCoach app to help smokers quit

The mobile anti-smoking campaign is part of the EC's on-going Ex-smokers are Unstoppable push

- PMLiVE

Orphan drugs economically viable for pharma

Drugs for rare diseases can generate as much lifetime revenue as medicines for common conditions

Interview: Jane Griffiths, Janssen EMEA

The company group chairman of Janssen EMEA tells Tom Meek why a focused product portfolio and expert staff are imperative to success

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links